Henriette Mersebach

Henriette Mersebach currently serves as the Executive Vice President of Research & Development at ALK, assuming office in March 2023 and contributing as a member of the Executive Leadership Team while overseeing R&D operations. Prior to this role, Henriette held multiple senior positions at Novo Nordisk, including Corporate Project Vice President for Rare Disease & Advanced Therapies and Executive Director of Clinical Development & Research. Henriette has extensive experience in global clinical development, product development strategies, and organizational leadership, with a medical background that includes clinical practice and research in internal medicine, endocrinology, and pediatrics. Educational qualifications include a PhD in Medicine from the University of Copenhagen and specialized training in Pharmaceutical Medicine from the University of Basel.